# Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users

> **NCT04636138** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 5 (actual)

## Conditions studied

- HMG-CoA Reductase Inhibitor Toxicity

## Interventions

- **OTHER:** Exercise

## Key facts

- **NCT ID:** NCT04636138
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-03
- **Primary completion:** 2023-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636138, "Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04636138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*